Published in Health Technol Assess on July 01, 2006
Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry (2006) 2.49
Evidence-based guidelines for mental, neurological, and substance use disorders in low- and middle-income countries: summary of WHO recommendations. PLoS Med (2011) 2.49
Attitudes toward pharmacological cognitive enhancement-a review. Front Syst Neurosci (2014) 1.05
Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHD. Pediatrics (2009) 1.02
The social and cultural construction of psychiatric knowledge: an analysis of NICE guidelines on depression and ADHD. Anthropol Med (2013) 0.97
Lack of adrenomedullin in the mouse brain results in behavioral changes, anxiety, and lower survival under stress conditions. Proc Natl Acad Sci U S A (2008) 0.93
Methylphenidate potentiates morphine-induced antinociception, hyperthermia, and locomotor activity in young adult rats. Pharmacol Biochem Behav (2008) 0.90
The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010). Child Adolesc Psychiatry Ment Health (2013) 0.88
Low dopamine function in attention deficit/hyperactivity disorder: should genotyping signify early diagnosis in children? Postgrad Med (2014) 0.88
A review of atomoxetine effects in young people with developmental disabilities. Res Dev Disabil (2014) 0.86
Cognitive biases can affect moral intuitions about cognitive enhancement. Front Syst Neurosci (2014) 0.86
Allelic variants of SNAP25 in a family-based sample of ADHD. J Neural Transm (Vienna) (2008) 0.84
Long-acting medications for the hyperkinetic disorders. A note on cost-effectiveness. Eur Child Adolesc Psychiatry (2007) 0.82
The NICE ADHD health technology assessment: a review and critique. Child Adolesc Psychiatry Ment Health (2008) 0.81
Cost effectiveness of guanfacine extended release as an adjunctive therapy to a stimulant compared with stimulant monotherapy for the treatment of attention-deficit hyperactivity disorder in children and adolescents. Pharmacoeconomics (2012) 0.80
Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride. Neuropsychiatr Dis Treat (2009) 0.80
Pathophysiology of ADHD and associated problems-starting points for NF interventions? Front Hum Neurosci (2015) 0.80
A review of modafinil film-coated tablets for attention-deficit/hyperactivity disorder in children and adolescents. Neuropsychiatr Dis Treat (2007) 0.79
Switching from methylphenidate immediate release to MPH-SODAS in attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry (2008) 0.79
A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain. BMC Psychiatry (2009) 0.78
Study protocol for a randomized controlled trial comparing the efficacy of a specialist and a generic parenting programme for the treatment of preschool ADHD. Trials (2014) 0.77
ADHD in children and adolescents. BMJ Clin Evid (2011) 0.76
An Evaluation on the Efficacy and Safety of Treatments for Attention Deficit Hyperactivity Disorder in Children and Adolescents: a Comparison of Multiple Treatments. Mol Neurobiol (2016) 0.76
Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD. BMC Psychiatry (2016) 0.75
A Cost-Utility Analysis of Lisdexamfetamine Versus Atomoxetine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Inadequate Response to Methylphenidate. CNS Drugs (2016) 0.75
Italian regional health service costs for diagnosis and 1-year treatment of ADHD in children and adolescents. Int J Ment Health Syst (2017) 0.75
Study of user experience of an objective test (QbTest) to aid ADHD assessment and medication management: a multi-methods approach. BMC Psychiatry (2017) 0.75
Comparative efficacy of methylphenidate and atomoxetine in the treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review and meta-analysis. Med J Islam Repub Iran (2016) 0.75
Diagnosis, treatment, and burden of illness among adults with attention-deficit/hyperactivity disorder in Europe. Pragmat Obs Res (2014) 0.75
Attention Deficit Hyperactivity Disorder Symptoms and Low Educational Achievement: Evidence Supporting A Causal Hypothesis. Behav Genet (2017) 0.75
Probabilistic Markov Model Estimating Cost Effectiveness of Methylphenidate Osmotic-Release Oral System Versus Immediate-Release Methylphenidate in Children and Adolescents: Which Information is Needed? Pharmacoeconomics (2015) 0.75
Methylphenidate use in children with attention deficit hyperactivity disorder. Rev Saude Publica (2015) 0.75
ADHD in children and adolescents. BMJ Clin Evid (2008) 0.75
The Satisfaction With Life Scale. J Pers Assess (1985) 27.94
NEUTRALIZATION OF THE VIRUS OF POLIOMYELITIS BY NASAL WASHINGS. J Exp Med (1917) 11.22
General practice fundholding. BMJ (1990) 6.43
Nucleotide sequence analysis of DNA. II. Complete nucleotide sequence of the cohesive ends of bacteriophage lambda DNA. J Mol Biol (1971) 5.80
Reliable genotyping of samples with very low DNA quantities using PCR. Nucleic Acids Res (1996) 5.73
Plastic mattresses and sudden infant death syndrome. Lancet (1995) 5.59
Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci U S A (1997) 5.54
Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet (1998) 5.34
Sequence and domain relationships of ntrC and nifA from Klebsiella pneumoniae: homologies to other regulatory proteins. EMBO J (1986) 5.20
Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain. IEEE Trans Med Imaging (1999) 5.07
The clinical evolution of Lyme arthritis. Ann Intern Med (1987) 5.02
Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings. Cochrane Database Syst Rev (2001) 4.94
The overdiagnosis of Lyme disease. JAMA (1993) 4.70
Interventions to prevent weight gain: a systematic review of psychological models and behaviour change methods. Int J Obes Relat Metab Disord (2000) 3.90
Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore) (1995) 3.85
The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening. Int J Obes Relat Metab Disord (2000) 3.83
Mapping motor inhibition: conjunctive brain activations across different versions of go/no-go and stop tasks. Neuroimage (2001) 3.51
Positive control and autogenous regulation of the nifLA promoter in Klebsiella pneumoniae. Nature (1983) 3.43
Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technol Assess (2004) 3.30
Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry (1996) 3.05
Effectiveness, efficiency, and NICE. BMJ (2001) 3.03
The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry (2006) 2.80
Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI. Am J Psychiatry (1999) 2.72
Retained intraaortic balloon. Ann Thorac Surg (1993) 2.72
Nasal tube switch: converting from a nasal to an oral endotracheal tube without extubation. J Oral Maxillofac Surg (1994) 2.69
The development and evaluation of a disease-specific quality of life measurement tool for shoulder instability. The Western Ontario Shoulder Instability Index (WOSI). Am J Sports Med (1999) 2.51
Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia (2011) 2.43
Generalisability in economic evaluation studies in healthcare: a review and case studies. Health Technol Assess (2004) 2.38
Stapled haemorrhoidopexy for the treatment of haemorrhoids: a systematic review. Colorectal Dis (2008) 2.35
Gardnerella vaginalis, anaerobes, and vaginal discharge. Lancet (1982) 2.34
Functional frontalisation with age: mapping neurodevelopmental trajectories with fMRI. Neurosci Biobehav Rev (2000) 2.31
Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest (1998) 2.27
A framework for clinical evaluation of diagnostic technologies. CMAJ (1986) 2.26
Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev (2005) 2.25
Successful parenteral penicillin therapy of established Lyme arthritis. N Engl J Med (1985) 2.23
"Sicca complex" in liver disease. Br Med J (1970) 2.22
Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. J Clin Oncol (1999) 2.19
Some guidelines on the use of cost effectiveness league tables. BMJ (1993) 2.16
Family involvement in weight control, weight maintenance and weight-loss interventions: a systematic review of randomised trials. Int J Obes Relat Metab Disord (2003) 2.13
Results of selective early operation in myelomeningocele. Arch Dis Child (1973) 2.12
Effects of a few food diet in attention deficit disorder. Arch Dis Child (1993) 2.12
When is it cost-effective to change the behavior of health professionals? JAMA (2001) 2.08
Substitution of a nursing-led inpatient unit for acute services: randomized controlled trial of outcomes and cost of nursing-led intermediate care. Age Ageing (2001) 2.07
X chromosome map at 75-kb STS resolution, revealing extremes of recombination and GC content. Genome Res (1997) 2.06
Conduct disorder and hyperactivity: I. Separation of hyperactivity and antisocial conduct in British child psychiatric patients. Br J Psychiatry (1986) 2.05
Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis. Health Technol Assess (2009) 2.03
Drug eluting stents. BMJ (2006) 2.02
Assessment of a selective medium for the isolation of Neisseria gonorrhoeae. Br J Vener Dis (1979) 2.01
Transmission of HIV-1 within a statewide prison system. AIDS (1988) 2.00
Temporal trends of human immunodeficiency virus type 1 (HIV-1) infection among inmates entering a statewide prison system, 1985-1987. J Acquir Immune Defic Syndr (1989) 1.96
Hyperactivity and delay aversion--I. The effect of delay on choice. J Child Psychol Psychiatry (1992) 1.95
European guidelines on managing adverse effects of medication for ADHD. Eur Child Adolesc Psychiatry (2010) 1.92
Noninvasive genetic tracking of the endangered Pyrenean brown bear population. Mol Ecol (1997) 1.90
Leaf temperatures of desert plants. Science (1968) 1.89
Proliferative diabetic retinopathy. Regression of optic disc neovascularization after retinal photocoagulation. Br J Ophthalmol (1970) 1.87
The incidence of HIV-1 infections in village populations of northern Thailand. AIDS (1994) 1.80
Efficiency in the National Health Service: lessons from abroad. Health Policy (1988) 1.79
Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery. Am J Psychiatry (1993) 1.78
Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection. Arch Intern Med (1993) 1.76
Should clinical trials with concurrent economic analyses be blinded? JAMA (1997) 1.76
An analysis of diabetic retinopathy. Q J Med (1973) 1.74
The development of a disease-specific quality of life measurement tool for osteoarthritis of the shoulder: The Western Ontario Osteoarthritis of the Shoulder (WOOS) index. Osteoarthritis Cartilage (2001) 1.71
How do teenagers and primary healthcare providers view each other? An overview of key themes. Br J Gen Pract (2001) 1.71
The clinical spectrum and treatment of Lyme disease. Yale J Biol Med (1985) 1.70
Sequence and molecular analysis of the nifL gene of Azotobacter vinelandii. Mol Microbiol (1993) 1.69
Hearing screening in newborns: systematic review of accuracy, effectiveness, and effects of interventions after screening. Arch Dis Child (2009) 1.64
Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Health Technol Assess (2005) 1.64
The long-term course of Lyme arthritis in children. N Engl J Med (1991) 1.63
Reporting guidelines for economic studies. Health Econ (1995) 1.62
Hyoscine butylbromide administered at the cecum increases polyp detection: a randomized double-blind placebo-controlled trial. Endoscopy (2012) 1.61
Risk factors associated with prevalent HIV-1 infection among pregnant women in Rwanda. National University of Rwanda-Johns Hopkins University AIDS Research Team. Int J Epidemiol (1994) 1.60
Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK. Br J Cancer (2006) 1.57
An economic evaluation of schizophrenia--1991. Soc Psychiatry Psychiatr Epidemiol (1995) 1.57
Treating hyperkinetic disorders in childhood. BMJ (1995) 1.56
Longitudinal assessment of the clinical and epidemiological features of Lyme disease in a defined population. J Infect Dis (1986) 1.56
Expression of HCLCA1 in cystic fibrosis lungs is associated with mucus overproduction. Eur Respir J (2004) 1.54
The effect on the function of the transcriptional activator NtrC from Klebsiella pneumoniae of mutations in the DNA-recognition helix. Nucleic Acids Res (1988) 1.54
Implications of the United Kingdom Prospective Diabetes Study for general practice care of type 2 diabetes. Br J Gen Pract (1999) 1.53
Uptake of glycylglycine by the scutellum of germinating barley grain. Plant Physiol (1978) 1.53
The economics of femorocrural reconstruction for critical leg ischemia with and without autologous vein. J Vasc Surg (1992) 1.51
What determines the cost-effectiveness of diabetes screening? Diabetologia (2006) 1.51
Delayed sleep phase syndrome. A chronobiological disorder with sleep-onset insomnia. Arch Gen Psychiatry (1981) 1.51
Distributed grey and white matter deficits in hyperkinetic disorder: MRI evidence for anatomical abnormality in an attentional network. Psychol Med (2001) 1.49
Absence of DNA sequences homologous to transposable element Tn5 (Kan) in the chromosome of Escherichia coli K-12. J Bacteriol (1978) 1.49
REM sleep episodes during the Multple Sleep Latency Test in narcoleptic patients. Electroencephalogr Clin Neurophysiol (1979) 1.49
The cost of treatment for post-herpetic neuralgia in the UK. Pharmacoeconomics (1994) 1.48
Guidelines for the clinical and economic evaluation of health care technologies. Soc Sci Med (1986) 1.47
Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol (2006) 1.46
Immune serum markers and CD4 cell counts in HIV-infected intravenous drug users. J Acquir Immune Defic Syndr (1992) 1.45
Use of a directly conjugated monoclonal anti-D (BRAD-3) for quantification of fetomaternal hemorrhage by flow cytometry. Transfusion (1996) 1.44
Escherichia coli and the human gut: some ecological considerations. J Appl Bacteriol (1981) 1.44
Cost-of-illness studies: a major headache? Pharmacoeconomics (1992) 1.44